STADA is an international pharmaceutical company that follows its mission of “Сaring for People’s Health as a Trusted Partner” for more than 125 years. STADA business pillars are Consumer Healthcare (CHC) products, generics, and specialty medicines (including biosimilars).
STADA products are available in more than 120 countries including Kazakhstan.
In 2022 the region formed by CIS countries became an independent business unit and was renamed to Eurasia with direct reporting into German headquarters. STADA Eurasia HQ is in Almaty. The company also registered STADA fully-fledged companies in the majority of the local markets, including Kazakhstan. Starting April 1st, 2023 STADA is distributing the portfolio of CHC products of Sanofi in the Eurasian region. STADA employs around 500 people in the region, approx. 200 of which are in Kazakhstan.